- Research works
- 8 ▼ 96% vs 2018-21
- Citations
- 91 11.6 per fractional work
- Top-10% rate
- 4.8% all institutions 10.0%
- Open access
- 26% world 40%
- International
- 6% world 18%
Not ranked overall: Siamab Therapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Siamab Therapeutics (United States) work in?
In all years, 69% of research at Siamab Therapeutics (United States) is in Life Sciences, 29% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (61%), Medicine (29%), Immunology and Microbiology (7%). It does 2.0× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 3 domains and 4 fields, with their numbers
- Life Sciences568.8%
- Health Sciences229.1%
- Medicine229.1%
- Physical Sciences02.2%
- Chemistry02.2%
Who are the top researchers at Siamab Therapeutics (United States)?
Ranked on the quality score, Jeff Behrens, David A. Eavarone and Jillian M. Prendergast lead among researchers whose main affiliation is Siamab Therapeutics (United States).
- 1
Jeff Behrens
United States · #1,786,033 worldwide 313 citations · 18 works
- 2
David A. Eavarone
United States · #2,012,717 worldwide 1.3k citations · 19 works
- 3
Jillian M. Prendergast
United States · #2,207,843 worldwide 518 citations · 30 works
Which research topics does Siamab Therapeutics (United States) publish most on?
By volume in 2022-now: Immunotherapy and Immune Responses, Wnt/β-catenin signaling in development and cancer, Sarcoma Diagnosis and Treatment and Cytokine Signaling Pathways and Interactions.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Immunotherapy and Immune Responses Immunology 0 works
- 2 Wnt/β-catenin signaling in development and cancer Molecular Biology 0 works
- 3 Sarcoma Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
- 4 Cytokine Signaling Pathways and Interactions Oncology 0 works
- 5 Cell Adhesion Molecules Research Immunology and Allergy 0 works
- 6 Glycosylation and Glycoproteins Research Molecular Biology 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Siamab Therapeutics (United States)'s research output changed?
Output in 2022-2025 was 96% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Newton
- William James College
- Andover Newton Theological School
- Boston Psychoanalytic Society and Institute
- Barrett Technology (United States)
- Newton Public Schools
- Karyopharm Therapeutics (United States)
- Lasell College
- Inflexxion (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Siamab Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.